For: | Akateh C, Ejaz AM, Pawlik TM, Cloyd JM. Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma. World J Hepatol 2020; 12(10): 693-708 [PMID: PMC7643214 DOI: 10.4254/wjh.v12.i10.693] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i10/693.htm |
Number | Citing Articles |
1 |
Mohamedraed Elshami, John B. Ammori, Jeffrey M. Hardacre, J. Eva Selfridge, David Bajor, Amr Mohamed, Sakti Chakrabarti, Amit Mahipal, Jordan M. Winter, Lee M. Ocuin. Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers. Journal of Surgical Research 2024; 295: 705 doi: 10.1016/j.jss.2023.11.067
|
2 |
Felix Krenzien, Nora Nevermann, Alina Krombholz, Christian Benzing, Philipp Haber, Uli Fehrenbach, Georg Lurje, Uwe Pelzer, Johann Pratschke, Moritz Schmelzle, Wenzel Schöning. Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach. Cancers 2022; 14(2): 362 doi: 10.3390/cancers14020362
|
3 |
Hauke Lang, Janine Baumgart, Stefan Heinrich, Tobias Huber, Lisa-Katharina Heuft, Rabea Margies, Jens Mittler, Felix Hahn, Tiemo S. Gerber, Friedrich Foerster, Arndt Weinmann, Jens U. Marquardt, Roman Kloeckner, Beate K. Straub, Fabian Bartsch. Liver Resection for Intrahepatic Cholangiocarcinoma—Single-Center Experience with 286 Patients Undergoing Surgical Exploration over a Thirteen Year Period. Journal of Clinical Medicine 2021; 10(16): 3559 doi: 10.3390/jcm10163559
|
4 |
Tiemo S. Gerber, Fabian Bartsch, Daniel C. Wagner, Mario Schindeldecker, Lisa-Katharina Heuft, Wilfried Roth, Hauke Lang, Beate K. Straub. Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data. Journal of Clinical Medicine 2021; 10(13): 2745 doi: 10.3390/jcm10132745
|
5 |
Linlin Yin, Si Zhao, Hanlong Zhu, Guozhong Ji, Xiuhua Zhang. Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91823-x
|
6 |
Richard X. Sousa Da Silva, Beat Muellhaupt, Philipp Dutkowski, Pierre-Alain Clavien. Liver transplantation for malignant liver tumors. iLIVER 2022; 1(1): 3 doi: 10.1016/j.iliver.2022.04.002
|
7 |
Alexandra Nassar, Stylianos Tzedakis, Rémy Sindayigaya, Christian Hobeika, Ugo Marchese, Julie Veziant, Tatiana Codjia, Aurélie Beaufrère, Alix Dhote, Marie Strigalev, François Cauchy, David Fuks. Factors of Early Recurrence After Resection for Intrahepatic Cholangiocarcinoma. World Journal of Surgery 2022; 46(10): 2459 doi: 10.1007/s00268-022-06655-1
|
8 |
Laura Alaimo, Henrique A. Lima, Zorays Moazzam, Yutaka Endo, Jason Yang, Andrea Ruzzenente, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W. Bauer, Sorin Alexandrescu, George A. Poultsides, Shishir K. Maithel, Hugo P. Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, François Cauchy, Bas Groot Koerkamp, Itaru Endo, Minoru Kitago, Timothy M. Pawlik. Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology 2023; 30(9): 5406 doi: 10.1245/s10434-023-13636-8
|
9 |
Robert P Jones. Lesional liver biopsies: better treatments, better studies, better science. British Journal of Surgery 2024; 111(5) doi: 10.1093/bjs/znae063
|
10 |
H Lang. Should all intrahepatic cholangiocarcinomas receive neoadjuvant chemotherapy before resection?. British Journal of Surgery 2021; 108(6): 598 doi: 10.1093/bjs/znab077
|
11 |
Sudha Kodali, Akshay Shetty, Soumya Shekhar, David W. Victor, Rafik M. Ghobrial. Management of Intrahepatic Cholangiocarcinoma. Journal of Clinical Medicine 2021; 10(11): 2368 doi: 10.3390/jcm10112368
|
12 |
Carlo Sposito, Marianna Maspero, Alessandro Cucchetti, Vincenzo Mazzaferro. A snapshot on current approaches to lymphadenectomy in liver resection for intrahepatic cholangiocarcinoma: results from an international survey. Updates in Surgery 2024; 76(5): 1797 doi: 10.1007/s13304-024-01852-0
|
13 |
Sebastian Ebel, Manuel Florian Struck, Florian van Boemmel, Anne Bettina Beeskow, Holger Gößmann, Timm Denecke. Chemosaturation of the Liver – an Update. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2023; 195(01): 30 doi: 10.1055/a-1858-3418
|
14 |
Woo Jin Choi, Fiorella Murillo Perez, Annabel Gravely, Tommy Ivanics, Marco P. A. W. Claasen, Liza Abraham, Phillipe Abreu, Robin Visser, Steven Gallinger, Bettina E. Hansen, Gonzalo Sapisochin. Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection. Annals of Hepato-Biliary-Pancreatic Surgery 2023; 27(2): 158 doi: 10.14701/ahbps.22-114
|
15 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Eleni Karapedi, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences 2022; 23(12): 6664 doi: 10.3390/ijms23126664
|
16 |
Ruofan Sheng, Beixuan Zheng, Yunfei Zhang, Wei Sun, Chun Yang, Mengsu Zeng. A preliminary study of developing an MRI-based model for postoperative recurrence prediction and treatment direction of intrahepatic cholangiocarcinoma. La radiologia medica 2024; 129(12): 1766 doi: 10.1007/s11547-024-01910-y
|
17 |
A. Dhote, S. Tzedakis, O. Itzaki Shapira, A. Nassar, K. Boudjema, D. Fuks. Actualités et perspectives dans la prise en charge chirurgicale et oncologique des cholangiocarcinomes intrahépatiques. Journal de Chirurgie Viscérale 2023; 160(5): 381 doi: 10.1016/j.jchirv.2023.04.017
|
18 |
McKenzie J. White, Eric H. Jensen, David G. Brauer. A Review of Resection and Surgical Ablation for Primary and Secondary Liver Cancers. Seminars in Interventional Radiology 2023; 40(06): 536 doi: 10.1055/s-0043-1777747
|
19 |
Alix Dhote, Stylianos Tzedakis, Ortal Itzaki Shapira, Alexandra Nassar, Karim Boudjema, David Fuks. Current status and perspectives in the surgical and oncological management of intrahepatic cholangiocarcinoma. Journal of Visceral Surgery 2023; 160(5): 346 doi: 10.1016/j.jviscsurg.2023.07.007
|
20 |
Woo Jin Choi, Richard Walker, Luckshi Rajendran, Owen Jones, Annie Gravely, Marina Englesakis, Steven Gallinger, Gideon Hirschfield, Bettina Hansen, Gonzalo Sapisochin. Call to Improve the Quality of Prediction Tools for Intrahepatic Cholangiocarcinoma Resection: A Critical Appraisal, Systematic Review, and External Validation Study. Annals of Surgery Open 2023; 4(3): e328 doi: 10.1097/AS9.0000000000000328
|
21 |
Xiaohui Wang, Ping Liang, Jie Yu, Jun-dong Yao, Fang-ying Fan, Xiaoling Yu, Zhi-gang Cheng, Zhi-yu Han, Fang-yi Liu, Jian-ping Dou. Contrast-enhanced ultrasound features predict the prognosis of percutaneous microwave ablation of intrahepatic cholangiocarcinoma. The British Journal of Radiology 2022; 95(1133) doi: 10.1259/bjr.20211379
|
22 |
Alix Dhote, Stylianos Tzedakis, Christian Hobeika, Ugo Marchese, Romain Coriat, Alexandra Nassar, Aurélie Beaufrère, Tatiana Codjia, Claire Goumard, Olivier Scatton, Anthony Dohan, Maxime Ronot, Benoit Terris, Mickael Lesurtel, Safi Dokmak, François Cauchy, David Fuks. Impact of induction therapy in locally advanced intrahepatic cholangiocarcinoma. European Journal of Surgical Oncology 2023; 49(10): 106939 doi: 10.1016/j.ejso.2023.05.014
|
23 |
Yao Xiao, Baoluhe Zhang, Jordan M. Cloyd, Laura Alaimo, Gang Xu, Shunda Du, Yilei Mao, Timothy M. Pawlik. Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping. Cancers 2022; 14(13): 3284 doi: 10.3390/cancers14133284
|
24 |
Francesca Caputo, Matteo Serenari, Andrea Palloni, Matteo Ravaioli, Giovanni Brandi, Matteo Cescon. Neoadjuvant chemotherapy alone or combined with trans-arterial therapies for downstaging unresectable intrahepatic cholangiocarcinoma to surgical resection: a narrative review. Hepatoma Research 2023; doi: 10.20517/2394-5079.2022.71
|
25 |
Abdullah Altaf, Mujtaba Khalil, Miho Akabane, Zayed Rashid, Jun Kawashima, Shahzaib Zindani, Andrea Ruzzenente, Luca Aldrighetti, Todd W. Bauer, Hugo P. Marques, Guillaume Martel, Irinel Popescu, Matthew J. Weiss, Minoru Kitago, George Poultsides, Shishir K. Maithel, Carlo Pulitano, Feng Shen, François Cauchy, Bas G. Koerkamp, Itaru Endo, Timothy M. Pawlik. Textbook outcome in liver surgery for intrahepatic cholangiocarcinoma: defining predictors of an optimal postoperative course using machine learning. HPB 2024; doi: 10.1016/j.hpb.2024.12.013
|
26 |
Gaya Spolverato, Dajana Glavas, D. Brock Hewitt, Zachary J Brown, Giulia Capelli, Francesca Bergamo, Mario Domenico Rizzato, Timothy M. Pawlik. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs. Expert Opinion on Pharmacotherapy 2022; 23(4): 473 doi: 10.1080/14656566.2021.2020250
|
27 |
Kylie E Zane, Jordan M Cloyd, Khalid S Mumtaz, Vibhor Wadhwa, Mina S Makary. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World Journal of Clinical Oncology 2021; 12(9): 725-745 doi: 10.5306/wjco.v12.i9.725
|
28 |
Kanokphorn Thonglert, Michael D. Chuong, Robert Herrera, Smith Apisarnthanarax. Advanced and emerging radiation therapy approaches for intrahepatic cholangiocarcinoma. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.47
|
29 |
Thomas An, Eric Wehrenberg-Klee. Trans-arterial chemoembolization and radioembolization for treatment of intrahepatic cholangiocarcinoma. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.60
|
30 |
Samantha M. Ruff, Jordan M. Cloyd, Timothy M. Pawlik. Annals of Surgical Oncology Practice Guidelines Series: Management of Primary Liver and Biliary Tract Cancers. Annals of Surgical Oncology 2023; 30(13): 7935 doi: 10.1245/s10434-023-14255-z
|
31 |
Bradley J. GIROD, Asha KANDATHIL. A review of F-18 fluorodeoxyglucose PET/CT in the evaluation and treatment of hepatobiliary tumors. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2025; 68(4) doi: 10.23736/S1824-4785.24.03574-X
|
32 |
Christopher W. Mangieri, Cristian D. Valenzuela, Matthew A. Strode, Richard A. Erali, Perry Shen, Russell Howerton, Clancy J. Clark. Effect of preoperative liver-directed therapy prior to hepatic resection. The American Journal of Surgery 2023; 225(4): 703 doi: 10.1016/j.amjsurg.2022.10.017
|
33 |
Woo Jin Choi, Tommy Ivanics, Marco P.A.W. Claasen, Steven Gallinger, Bettina Hansen, Gonzalo Sapisochin. Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatectomy for intrahepatic cholangiocarcinoma? ACS-NSQIP propensity-matched analysis. HPB 2022; 24(9): 1535 doi: 10.1016/j.hpb.2022.03.010
|
34 |
Jiawei Zhang, Qiming Huang, Yi Yang, Jiahui Zhang, Xueting Fang, Yubin Yang, Huifang Liang, Wei Wang, Yanjun Wang. A novel prognostic system combining carbonic anhydrase II and preoperative CA19‐9 for intrahepatic cholangiocarcinoma after curative resection. Cancer 2023; 129(7): 1030 doi: 10.1002/cncr.34639
|
35 |
K Kobryn. Bronchobiliary Fistula: A Challenging Opponent to Treat in Stage IV intrahepatic Cholangiocarcinoma (iCC) Patients. Journal of Surgery Research and Practice 2023; : 1 doi: 10.46889/JSRP.2023.4305
|
36 |
Tianzuo Zhan, Johannes Betge, Nadine Schulte, Lena Dreikhausen, Michael Hirth, Moying Li, Philip Weidner, Antonia Leipertz, Andreas Teufel, Matthias P. Ebert. Digestive cancers: mechanisms, therapeutics and management. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-024-02097-4
|
37 |
Michail Papamichail, Michail Pizanias, Nigel D Heaton. Minimizing the risk of small-for-size syndrome after liver surgery. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 113 doi: 10.1016/j.hbpd.2021.12.005
|
38 |
Woo Jin Choi, Tommy Ivanics, Annabel Gravely, Steven Gallinger, Gonzalo Sapisochin, Grainne M. O’Kane. Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring. Annals of Surgical Oncology 2023; 30(6): 3849 doi: 10.1245/s10434-023-13126-x
|
39 |
Nikolaos Serifis, Diamantis I Tsilimigras, Daniel J Cloonan, Timothy M Pawlik. Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma. Hepatic Medicine: Evidence and Research 2021; : 93 doi: 10.2147/HMER.S278136
|
40 |
Tatsuya Ioka, Yoshitaro Shindo, Makoto Ueno, Hiroaki Nagano. Current progress in perioperative chemotherapy for biliary tract cancer. Annals of Gastroenterological Surgery 2023; 7(4): 565 doi: 10.1002/ags3.12691
|
41 |
Frederik J H Hoogwater, Hendrien Kuipers, Vincent E de Meijer, Charlotte Maulat, Fabrice Muscari, Wojciech G Polak, Bart van Hoek, Caroline Jézéquel, Ian P J Alwayn, Jan N M Ijzermans, Kayvan Mohkam, Jean-Yves Mabrut, Frederike G I Van Vilsteren, Jean-Philippe Adam, Laurence Chiche, Alexandre Chebaro, Emmanuel Boleslawski, Jeroen Dubbeld, Sarwa Darwish Murad, Michel Rayar, Robert J Porte. Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study. BJS Open 2023; 7(2) doi: 10.1093/bjsopen/zrad025
|
42 |
Jinyu Lin, Haisu Tao, Xiangdong Yuan, Jian Yang. Laparoscopic Radical Resection After Neoadjuvant Therapy for Intrahepatic Cholangiocarcinoma with Hepatic Hilus Involvement. Annals of Surgical Oncology 2024; 31(10): 6564 doi: 10.1245/s10434-024-15772-1
|
43 |
Eliza W. Beal, Jordan M. Cloyd, Timothy M. Pawlik. Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles. Journal of Clinical Medicine 2020; 10(1): 104 doi: 10.3390/jcm10010104
|
44 |
Guergana Panayotova, Jarot Guerra, James V. Guarrera, Keri E. Lunsford. The Role of Surgical Resection and Liver Transplantation for the Treatment of Intrahepatic Cholangiocarcinoma. Journal of Clinical Medicine 2021; 10(11): 2428 doi: 10.3390/jcm10112428
|
45 |
Hyungjin Rhee, Sang Hyun Choi, Ji Hoon Park, Eun‐Suk Cho, Suk‐Keu Yeom, Sumi Park, Kyunghwa Han, Seung Soo Lee, Mi‐Suk Park. Preoperative magnetic resonance imaging‐based prognostic model for mass‐forming intrahepatic cholangiocarcinoma. Liver International 2022; 42(4): 930 doi: 10.1111/liv.15196
|
46 |
Saurav Verma, Natalie Grindrod, Daniel Breadner, Michael Lock. The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review. Cancers 2024; 16(9): 1776 doi: 10.3390/cancers16091776
|
47 |
Zijiao Yang, Xia Jiang. Efficacy and safety comparison of neoadjuvant chemotherapy followed by surgery and upfront surgery for treating intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02754-y
|
48 |
Abdullah Altaf, Yutaka Endo, Alfredo Guglielmi, Luca Aldrighetti, Todd W. Bauer, Hugo P. Marques, Guillaume Martel, Sorin Alexandrescu, Mathew J. Weiss, Minoru Kitago, George Poultsides, Shishir K. Maithel, Carlo Pulitano, Feng Shen, François Cauchy, Bas G. Koerkamp, Itaru Endo, Timothy M. Pawlik. Upfront surgery for intrahepatic cholangiocarcinoma: Prediction of futility using artificial intelligence. Surgery 2025; 179: 108809 doi: 10.1016/j.surg.2024.06.059
|
49 |
D. Brock Hewitt, Zachary J. Brown, Timothy M Pawlik. Surgical management of intrahepatic cholangiocarcinoma. Expert Review of Anticancer Therapy 2022; 22(1): 27 doi: 10.1080/14737140.2022.1999809
|
50 |
Ze Zhang, Wenwen Zhang, Hongguang Wang, Bingyang Hu, Zhanbo Wang, Shichun Lu. Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma With a High Tumor Mutational Burden and PD-L1 Expression by PD-1 Blockade Combined With Tyrosine Kinase Inhibitors: A Case Report. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.744571
|
51 |
Shraddha Patkar, Vikas Gupta, Krunal Khobragade, Mahesh Goel. The reality of cholangiocarcinoma in India– real world data from a tertiary referral centre. HPB 2022; 24(9): 1511 doi: 10.1016/j.hpb.2022.03.007
|
52 |
Rebecca Marcus, Wade Christopher, Jennifer Keller, Sean Nassoiy, Shu-Ching Chang, Melanie Goldfarb, Ronald Wolf, Zeljka Jutric. Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade. Cancers 2022; 14(17): 4320 doi: 10.3390/cancers14174320
|